MACLEODS PHARMA USA, INC recalls Levothyroxine Sodium Tablets USP 150 mcg
- Recalling company
- MACLEODS PHARMA USA, INC
- Product
- Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
- Reason
- Subpotent Drug
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Feb 26, 2026
- Reported
- Apr 1, 2026
- Distribution
- Nationwide
- Status
- Ongoing
- Quantity
- 1315 bottles
- Lot / codes
- Lot 16240062A, exp date 3/2026
- Company location
- Princeton, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0403-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0403-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.